B-cell lymphoma – Basic Information

Go back

B-cell lymphoma is a type of blood cancer that develops in the lymphatic system, where abnormal white blood cells multiply and form tumors throughout the body. While some people can have this condition for years without knowing it, others may experience symptoms like severe night sweats, extreme tiredness, and swollen lymph nodes. Understanding this disease can help patients and their families navigate the challenges of diagnosis and treatment.

Epidemiology: How Common Is B-Cell Lymphoma?

B-cell lymphoma represents a significant portion of blood cancers diagnosed worldwide. According to available data, B-cell lymphomas account for approximately 85% of all non-Hodgkin lymphoma cases, which is a broad category of blood cancers that affect the lymphatic system.[1] Non-Hodgkin lymphoma itself is a relatively common cancer, though it is still far less common than many other cancer types.

In the United States, the American Cancer Society estimates that around 80,600 people will receive a non-Hodgkin lymphoma diagnosis in 2024. When we put this in perspective by comparing it to the overall cancer burden, more than 2 million people will learn they have some type of cancer that same year. This means that while B-cell lymphoma is a serious concern, it represents a smaller fraction of all cancer diagnoses.[1]

The disease tends to affect certain age groups more than others. Many types of B-cell lymphoma are more common in older adults, particularly those over the age of 60. For example, diffuse large B-cell lymphoma, which is the most common subtype, generally increases with age and most patients are diagnosed after reaching their 60s.[8] However, some forms like Burkitt lymphoma are rare and typically affect children, showing that age patterns vary considerably depending on the specific type.[3]

Men appear to be slightly more affected by certain types of B-cell lymphoma than women. Mantle cell lymphoma, for instance, affects 1 in 20 people with lymphoma and is more common in older adults and men specifically.[3] More than 18,000 people are diagnosed with diffuse large B-cell lymphoma each year in the United States alone, accounting for about 22% of newly diagnosed B-cell non-Hodgkin lymphoma cases.[8]

Causes: What Leads to B-Cell Lymphoma?

B-cell lymphoma develops when something goes wrong with the genetic instructions inside B-cells, which are a type of white blood cell that normally helps fight infections. The disease begins when changes occur in the DNA, which is the genetic code that tells cells how to function. These changes alter the genetic instructions in ways that prevent the B-cell from doing its job of fighting infection. Instead, the abnormal cell just grows and divides uncontrollably.[6]

In most children and young adults who develop B-cell lymphoma, doctors cannot identify a specific cause for these genetic changes. The alterations seem to happen spontaneously without a clear trigger. This can be frustrating for patients and families who want to understand why the disease occurred, but it reflects the complex and often unpredictable nature of cancer development.[6]

However, certain factors are known to increase the likelihood that someone will develop B-cell lymphoma. People who have inherited conditions that affect DNA repair or who have weakened immune systems face higher risks. Those who take medications that suppress the immune system, such as people who have received organ transplants, are also more vulnerable to developing this type of cancer.[6]

In B-cell lymphoma, abnormal lymphocytes, which are white blood cells, multiply and form tumors. The lymphatic system is a large network of organs, vessels, and tissues spread throughout the entire body, which explains why B-cell lymphoma can develop in many different locations and cause varying symptoms depending on where the tumors form.[1]

Risk Factors: Who Is More Likely to Develop B-Cell Lymphoma?

Several groups of people face elevated risks for developing B-cell lymphoma based on their health status, medical history, and certain inherited conditions. Understanding these risk factors can help with early detection and monitoring, though having a risk factor does not mean someone will definitely develop the disease.

People with compromised immune systems are at higher risk. This includes individuals who have HIV/AIDS, which weakens the body’s ability to fight diseases. It also includes people who have received organ transplants and must take immunosuppressive medications to prevent organ rejection. These medications, while necessary for transplant success, make the immune system less able to control abnormal cell growth.[6]

Certain genetic conditions that affect how cells repair their DNA also increase the risk. These inherited disorders make it more likely that genetic errors will accumulate in cells over time, potentially leading to cancer. People born with immune deficiency disorders face similar elevated risks because their bodies cannot effectively monitor and eliminate abnormal cells.[6]

Age is another significant risk factor. Many types of B-cell lymphoma become more common as people get older, with the majority of cases diagnosed in people over 60 years old. This age-related increase likely reflects the accumulation of genetic changes over a lifetime, as well as changes in immune system function that come with aging.[8]

Gender plays a role in some subtypes. Men are more likely than women to develop certain forms like mantle cell lymphoma. However, this pattern is not universal across all B-cell lymphoma types, and both men and women can develop any form of the disease.[3]

⚠️ Important
Before starting treatment for B-cell lymphoma, doctors will perform blood tests to check for hepatitis B virus infection. If someone has had hepatitis B in the past or currently has it, the virus can reactivate during lymphoma treatment, which can lead to serious liver problems. Your healthcare provider needs to know about any history of hepatitis B to protect your liver health during treatment.[15]

Symptoms: What Does B-Cell Lymphoma Feel Like?

One of the challenging aspects of B-cell lymphoma is that many people can have the disease for months or even years before developing any noticeable symptoms. Some types, like follicular lymphoma, are often discovered accidentally when someone receives medical tests or treatment for a completely unrelated condition. This silent nature in the early stages makes it harder to detect without routine medical care.[1]

When symptoms do appear, they can vary significantly depending on which type of B-cell lymphoma someone has and where in the body the disease is located. However, several symptoms are common across many different subtypes and can serve as warning signs that something is wrong.

Swollen lymph nodes are one of the most common symptoms. These appear as painless lumps that people might notice in their neck, armpits, or groin. The lymph nodes feel like small, firm bumps under the skin that do not hurt when pressed. This painless quality is important because swollen lymph nodes from infections usually do cause discomfort, making the painless swelling more concerning for lymphoma.[6]

Drenching night sweats represent another characteristic symptom. These are not mild sweating episodes but rather severe sweating that soaks through sleepwear and bedding, requiring people to change their clothes or sheets during the night. This symptom can be extremely disruptive to sleep and quality of life.[1]

Profound fatigue affects many people with B-cell lymphoma. This goes beyond normal tiredness from a busy day or lack of sleep. Instead, it is a persistent, overwhelming exhaustion that does not improve with rest and makes it difficult to carry out daily activities.[1]

Abdominal pain can occur when lymphoma develops in the belly area. Some types of B-cell lymphoma start in the stomach or other parts of the digestive system, causing pain that persists or gradually worsens over time. This pain might be accompanied by a feeling of fullness or a swollen abdomen if the liver or spleen becomes enlarged.[1]

Other symptoms that people with B-cell lymphoma might experience include unexplained weight loss, fever that comes and goes, coughing or difficulty breathing if the chest is affected, and in rare cases, skin changes if the lymphoma affects the skin directly. The combination and severity of symptoms depend on how aggressive the lymphoma is and where it has spread in the body.[6]

Prevention: Can B-Cell Lymphoma Be Prevented?

Unfortunately, because the exact causes of B-cell lymphoma remain unknown in most cases, there are no proven strategies for preventing the disease in the general population. Unlike some cancers where lifestyle changes can significantly reduce risk, such as lung cancer and smoking cessation, B-cell lymphoma does not have clear preventable risk factors that apply to most people.

For individuals with known risk factors, the focus shifts to vigilance and monitoring rather than true prevention. People with immune system disorders or those taking immunosuppressive medications should maintain regular contact with their healthcare providers and report any unusual symptoms promptly. While this approach cannot prevent lymphoma from developing, it can lead to earlier detection if it does occur.

People who have had hepatitis B infection need to inform their doctors about this history. While having hepatitis B does not cause B-cell lymphoma, knowing about this virus is crucial if lymphoma develops and treatment begins, because lymphoma treatments can reactivate the virus and cause serious complications.[15]

Maintaining overall good health through a balanced diet, regular exercise, adequate sleep, and stress management may support immune system function, though these measures have not been proven to specifically prevent B-cell lymphoma. Some people who develop lymphoma wonder about diet changes, and while a healthy, plant-based diet with plenty of fruits, vegetables, and whole grains is beneficial for general health and wellbeing during and after treatment, there is no evidence that specific dietary changes can prevent lymphoma from occurring in the first place.[20]

Pathophysiology: What Happens in the Body?

To understand what goes wrong in B-cell lymphoma, it helps to know what B-cells normally do in a healthy body. B-cells are specialized white blood cells that form part of the immune system. Their main job is to make antibodies, which are proteins that recognize and help destroy bacteria, viruses, and other threats to health. B-cells are found throughout the lymphatic system, particularly in lymph nodes, spleen, bone marrow, and other lymphoid tissues.[6]

In B-cell lymphoma, genetic changes transform normal B-cells into cancer cells. These abnormal B-cells no longer perform their infection-fighting duties. Instead, they multiply rapidly and uncontrollably, crowding out normal, healthy cells. As these cancer cells accumulate, they form tumors in lymph nodes or other parts of the lymphatic system, causing the nodes to swell and grow larger than normal.[6]

The lymphatic system spans the entire body, consisting of organs like the spleen and thymus, vessels that carry lymph fluid, and lymph nodes scattered throughout. Because this system is so widespread, B-cell lymphoma can start in many different locations. Some types begin in lymph nodes in the neck or chest, while others start in organs like the stomach, skin, bone marrow, or even the brain and spinal cord.[2]

As the disease progresses, lymphoma cells can travel through the lymphatic system or bloodstream to other parts of the body. This spread, called metastasis, allows the cancer to affect multiple sites. Advanced B-cell lymphoma may involve the bone marrow where new blood cells are made, the central nervous system including the brain and spinal cord, the liver, spleen, and reproductive organs.[6]

Different types of B-cell lymphoma grow at different speeds. Aggressive or fast-growing types like Burkitt lymphoma and diffuse large B-cell lymphoma can spread quickly from the lymphatic system to other organs, requiring immediate treatment. Indolent or slow-growing types like follicular lymphoma and chronic lymphocytic leukemia develop much more gradually over months or years, sometimes not requiring treatment right away.[1]

The cancer cells in B-cell lymphoma look different under a microscope compared to normal B-cells. They may be larger, have abnormal shapes, or show other features that help pathologists identify the specific subtype. For example, diffuse large B-cell lymphoma is named for the large size of the cancer cells and their diffuse, scattered pattern in affected tissues. Understanding these cellular characteristics helps doctors predict how the disease will behave and choose the most appropriate treatments.[7]

As lymphoma cells multiply and tumors grow, they interfere with normal body functions in several ways. Enlarged lymph nodes can press on nearby structures, causing pain or breathing difficulties if they are in the chest. When lymphoma affects the bone marrow, it can reduce production of normal blood cells, leading to anemia, increased infections, and easy bleeding. If lymphoma spreads to the digestive system, it can cause abdominal pain, nausea, or intestinal blockages.[1]

Ongoing Clinical Trials on B-cell lymphoma

  • A study comparing AZD0486 after reduced chemotherapy versus standard chemotherapy in older or unfit patients with newly diagnosed large B-cell lymphoma

    Recruiting

    1 1 1 1
    Investigated diseases:
    Belgium Poland
  • Study of LUMC-BOB1-B7-TCR.

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on Immunotherapy with HSP-CAR19M and Drug Combination for Adults with B-cell Non-Hodgkin Lymphoma

    Recruiting

    1 1 1
    Spain
  • Study of IDP-121 for Patients with Relapsed or Refractory Multiple Myeloma, B-cell Lymphoma, or Chronic Lymphocytic Leukemia

    Recruiting

    1 1
    Investigated drugs:
    Spain
  • Study of valemetostat tosylate tablets in patients with relapsed or refractory B-cell lymphoma, including aggressive B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, and Hodgkin lymphoma

    Recruiting

    1 1
    Belgium France
  • Long-Term Follow-Up Study for Patients Treated with CAR T-Cell Therapy Using PHE885, YTB323, and Tisagenlecleucel

    Recruiting

    1 1 1 1
    Austria Belgium Denmark Finland France Germany +6
  • Long-term Study of Ibrutinib for Patients with B-cell Non-Hodgkin’s Lymphoma and Chronic Graft Versus Host Disease

    Recruiting

    1 1 1 1
    Investigated drugs:
    Belgium France Germany Greece Italy Poland +2
  • Study on UCART20x22 for Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Using a Drug Combination

    Recruiting

    1 1 1
    France Italy Spain
  • Study of Pembrolizumab for Children with Advanced Melanoma or PD-L1 Positive Solid Tumors and Lymphoma

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy The Netherlands Portugal Sweden
  • Study on the Safety and Effectiveness of AZD5492 Alone or with Other Treatments for Adults with Relapsed or Refractory B-Cell Blood Cancers

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Denmark France Germany Italy Spain

References

https://my.clevelandclinic.org/health/diseases/22030-b-cell-lymphoma

https://www.mayoclinic.org/diseases-conditions/b-cell-lymphoma/symptoms-causes/syc-20586599

https://www.webmd.com/cancer/lymphoma/what-is-b-cell-lymphoma

https://www.cancer.org/cancer/types/non-hodgkin-lymphoma/about/b-cell-lymphoma.html

https://www.mdanderson.org/cancer-types/non-hodgkin-lymphoma/b-cell-lymphoma.html

https://www.cincinnatichildrens.org/health/b/b-cell-lymphoma

https://en.wikipedia.org/wiki/B-cell_lymphoma

https://lymphoma.org/understanding-lymphoma/aboutlymphoma/nhl/dlbcl/

https://www.mayoclinic.org/diseases-conditions/b-cell-lymphoma/diagnosis-treatment/drc-20586601

https://my.clevelandclinic.org/health/diseases/22030-b-cell-lymphoma

https://lymphoma.org/understanding-lymphoma/aboutlymphoma/nhl/dlbcl/dlbcltreatment/

https://www.cancer.gov/types/lymphoma/hp/aggressive-b-cell-lymphoma-treatment-pdq

https://www.masseycancercenter.org/cancer-types-and-treatments/cancer-types/non-hodgkin-lymphoma/treatment/

https://www.mdanderson.org/cancer-types/non-hodgkin-lymphoma/b-cell-lymphoma.html

https://www.rituxan.com/nhl/about-rituxan/diffuse-large-b-cell-lymphoma.html

https://pmc.ncbi.nlm.nih.gov/articles/PMC3497705/

https://my.clevelandclinic.org/health/diseases/22030-b-cell-lymphoma

https://lymphoma-action.org.uk/about-lymphoma/living-and-beyond-lymphoma

https://www.cancercare.org/diagnosis/lymphoma

https://www.mylymphomateam.com/resources/diet-and-lymphoma-nutrition-tips-for-feeling-your-best

https://health.clevelandclinic.org/life-with-lymphoma

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

Can B-cell lymphoma be cured?

Yes, many types of B-cell lymphoma can be cured, particularly aggressive forms treated with intensive chemotherapy. Treatments can put some types into long-term remission that effectively cures them, though the cancer can sometimes come back. More than half of patients with diffuse large B-cell lymphoma can now be cured with modern treatments.[1][16]

Is B-cell lymphoma genetic or hereditary?

In most cases, B-cell lymphoma is not inherited from parents. The genetic changes that cause the disease usually occur spontaneously during a person’s lifetime. However, people born with certain DNA repair defects or immune deficiencies do have higher risks of developing the disease.[6]

What is the difference between aggressive and indolent B-cell lymphoma?

Aggressive B-cell lymphomas are fast-growing and can quickly spread from the lymphatic system to other organs, requiring immediate treatment. Indolent types grow more slowly, and people can have them for months or years before developing symptoms. Paradoxically, aggressive types are often more curable with intensive treatment, while indolent types may not be cured but can be controlled for many years.[1]

How is B-cell lymphoma diagnosed?

Diagnosis typically begins with a physical exam checking for swollen lymph nodes and enlarged organs, followed by blood tests and imaging scans like CT, PET, or MRI. The definitive diagnosis requires a biopsy, where a sample of tissue is removed and examined under a microscope to look for cancer cells and identify the specific subtype.[9]

What is the survival rate for B-cell lymphoma?

Survival rates vary widely depending on the specific type and stage of B-cell lymphoma. Overall, with modern treatment, the five-year overall survival rate for non-Hodgkin lymphoma is over 60%. More than 70% of patients with aggressive types can be cured, while indolent types often have long-term survival of many years even though they may not be completely cured.[12]

🎯 Key takeaways

  • B-cell lymphoma accounts for 85% of all non-Hodgkin lymphomas and includes many different subtypes, each requiring specific treatment approaches.[1]
  • Many people can have indolent B-cell lymphoma for years without symptoms, making it a particularly silent disease that is sometimes discovered accidentally.[1]
  • The disease develops when genetic changes transform normal infection-fighting B-cells into cancer cells that multiply uncontrollably instead of protecting the body.[6]
  • Common symptoms include painless swollen lymph nodes, drenching night sweats, extreme fatigue, and unexplained weight loss, though not everyone experiences all of these.[1]
  • People with weakened immune systems, those taking immunosuppressive medications, and individuals with certain inherited DNA repair defects face higher risks.[6]
  • Aggressive B-cell lymphomas grow quickly and spread rapidly but paradoxically are often more curable with intensive treatment than slow-growing types.[1]
  • Modern treatments can cure more than half of all patients with aggressive diffuse large B-cell lymphoma, the most common subtype affecting over 18,000 Americans yearly.[8][16]
  • Because the lymphatic system extends throughout the entire body, B-cell lymphoma can develop in many locations including lymph nodes, bone marrow, skin, stomach, brain, and other organs.[2]